Video

Dr Dana Goldman Explains the Cons of Restrictive Prior Authorization Policies

Restrictive prior authorization policies have made had a negative impact on schizophrenia patients, who tend to be an already-difficult population to treat, explained Dana Goldman, PhD.

PhD

Schizophrenia is a very large public health problem, but patients with the illness are a difficult population to treat and restrictive prior authorization policies have reduced adherence, explained Dana Goldman, , the Leonard D. Schaeffer Chair and Director of the Schaeffer Center for Health Policy and Economics at the University of Southern California.

He added that restrictive prior authorization policies have increased hospitalizations among these patients and even added more patients to the prison population.

"The social cost can be quite large as a result of restrictive policies," he said.

Related Videos
Shawn Griffin, MD, sitting for a video interview
5 experts are featured in this series
5 experts are featured in this series
Christine Funke, MD
John Michael O'Brien, PharmD, MPH
Kathi Henson, MBA, sitting for a video interview
Mike Fazio, Navista, Cardinal Health
1 expert in this video
1 expert in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo